Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ascendis Pharma A (ASND) Return on Assets (2016 - 2025)

Historic Return on Assets for Ascendis Pharma A (ASND) over the last 11 years, with Q4 2025 value amounting to 0.15%.

  • Ascendis Pharma A's Return on Assets rose 1700.0% to 0.15% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.15%, marking a year-over-year increase of 1700.0%. This contributed to the annual value of 0.16% for FY2025, which is 2000.0% up from last year.
  • Latest data reveals that Ascendis Pharma A reported Return on Assets of 0.15% as of Q4 2025, which was up 1700.0% from 0.18% recorded in Q3 2025.
  • Over the past 5 years, Ascendis Pharma A's Return on Assets peaked at 0.15% during Q4 2025, and registered a low of 0.68% during Q3 2023.
  • Over the past 5 years, Ascendis Pharma A's median Return on Assets value was 0.4% (recorded in 2021), while the average stood at 0.41%.
  • Its Return on Assets has fluctuated over the past 5 years, first plummeted by -3500bps in 2023, then soared by 3700bps in 2025.
  • Quarter analysis of 5 years shows Ascendis Pharma A's Return on Assets stood at 0.24% in 2021, then plummeted by -104bps to 0.5% in 2022, then dropped by -11bps to 0.55% in 2023, then skyrocketed by 41bps to 0.32% in 2024, then skyrocketed by 53bps to 0.15% in 2025.
  • Its Return on Assets was 0.15% in Q4 2025, compared to 0.18% in Q3 2025 and 0.24% in Q2 2025.